Tag: respiratory disease
Australia invests in local manufacturing of AI tools for respiratory disease
Australian health technology company Diag-Nose.io has secured $3 million in federal funding to advance local manufacturing and clinical validation of an artificial intelligence-powered diagnostic platform designed to improve treatment of respiratory disease.
Featured Article
Reducing downtime through real-time shop floor insights with Minitab’s Prolink
Unplanned downtime remains one of the most costly – and often misunderstood – challenges on the manufacturing floor.
